OBJECTIVES: Unsedated office-based laryngeal laser surgery (UOLS) is now an effective alternative to traditional operating room-based suspension microdirect laryngoscopy under general anesthesia. This procedure includes pulsed dye laser (PDL) treatment of recurrent respiratory papillomas, granulomas, leukoplakia, and polypoid degeneration. The objective of this study was to determine the magnitude of the cost savings derived by moving these types of procedures from the operating room to the office setting. METHODS: Retrospective cost-identification analysis was performed by comparing the billing records of patients who underwent surgical laser treatment for recurrent respiratory papillomatosis in the operating room to the costs and charges for patients who underwent similar procedures with the in-office PDL. RESULTS: In performing surgery with the PDL in the office, the average cost savings was more than $5,000 per case. Current reimbursement rates do not cover the cost of performing UOLS. CONCLUSIONS: The potential cost savings of UOLS are tremendous; however, at present significant financial disincentives prevent proliferation of this technology.
OBJECTIVES: Unsedated office-based laryngeal laser surgery (UOLS) is now an effective alternative to traditional operating room-based suspension microdirect laryngoscopy under general anesthesia. This procedure includes pulsed dye laser (PDL) treatment of recurrent respiratory papillomas, granulomas, leukoplakia, and polypoid degeneration. The objective of this study was to determine the magnitude of the cost savings derived by moving these types of procedures from the operating room to the office setting. METHODS: Retrospective cost-identification analysis was performed by comparing the billing records of patients who underwent surgical laser treatment for recurrent respiratory papillomatosis in the operating room to the costs and charges for patients who underwent similar procedures with the in-office PDL. RESULTS: In performing surgery with the PDL in the office, the average cost savings was more than $5,000 per case. Current reimbursement rates do not cover the cost of performing UOLS. CONCLUSIONS: The potential cost savings of UOLS are tremendous; however, at present significant financial disincentives prevent proliferation of this technology.
Authors: Isabelle A Chan; Jesse F d'Almeida; Alex J Chiluisa; Thomas L Carroll; Yuxiang Liu; Loris Fichera Journal: Proc SPIE Int Soc Opt Eng Date: 2021-02-15
Authors: Jeffrey M Straub; Kevin A Calamari; Timothy J Shin; Sarah A Janse; Lowell A Forrest; Brad W deSilva; Laura A Matrka Journal: Laryngoscope Investig Otolaryngol Date: 2020-09-02
Authors: Yan Yan; Aleksandra E Olszewski; Matthew R Hoffman; Peiyun Zhuang; Charles N Ford; Seth H Dailey; Jack J Jiang Journal: J Voice Date: 2009-05-31 Impact factor: 2.009
Authors: Caitlin Bertelsen; Hagit Shoffel-Havakuk; Karla O'Dell; Michael M Johns; Lindsay S Reder Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-03-01 Impact factor: 6.223